(0.04%) 5 519.25 points
(0.11%) 39 889 points
(0.11%) 19 773 points
(-0.05%) $81.59
(0.46%) $2.82
(-0.24%) $2 338.70
(0.20%) $29.59
(0.43%) $1 006.10
(0.06%) $0.932
(-0.11%) $10.52
(-0.01%) $0.788
(-0.85%) $87.24
1.50% $ 0.690
Live Chart Being Loaded With Signals
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company\'s targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake...
Stats | |
---|---|
Dzisiejszy wolumen | 131 826 |
Średni wolumen | 378 283 |
Kapitalizacja rynkowa | 24.77M |
EPS | $-0.140 ( Q1 | 2024-05-15 ) |
Następna data zysków | ( $-0.450 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.110 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00700 (1.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-05 | Powell Lynne | Buy | 12 500 | Common Stock |
2024-06-05 | Powell Lynne | Buy | 12 500 | Stock Option (Right to Buy) |
2024-06-05 | Howe Jill Ann | Buy | 12 500 | Common Stock |
2024-06-05 | Howe Jill Ann | Buy | 12 500 | Stock Option (Right to Buy) |
2024-06-05 | Kotzin Brian L. | Buy | 12 500 | Common Stock |
INSIDER POWER |
---|
-15.35 |
Last 99 transactions |
Buy: 136 842 356 | Sell: 120 266 363 |
Wolumen Korelacja
Biora Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
OZEM | 1 |
IRON | 0.952 |
PMEC | 0.944 |
BKHAR | 0.934 |
RUMBW | 0.913 |
DCIBX | 0.904 |
JNVR | 0.899 |
CA | 0.899 |
PLUR | 0.89 |
GWMTX | 0.89 |
10 Najbardziej negatywne korelacje | |
---|---|
AILEW | -0.922 |
BOTT | -0.914 |
CCSB | -0.91 |
EVAX | -0.903 |
MTEN | -0.883 |
OPTZ | -0.88 |
BLDEW | -0.861 |
CNRLX | -0.851 |
GECCI | -0.845 |
DTI | -0.84 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Biora Therapeutics, Inc. Korelacja - Waluta/Towar
Biora Therapeutics, Inc. Finanse
Annual | 2023 |
Przychody: | $4 000.00 |
Zysk brutto: | $-551 000 (-13 775.00 %) |
EPS: | $-7.87 |
FY | 2023 |
Przychody: | $4 000.00 |
Zysk brutto: | $-551 000 (-13 775.00 %) |
EPS: | $-7.87 |
FY | 2022 |
Przychody: | $305 000 |
Zysk brutto: | $-602 000 (-197.38 %) |
EPS: | $-6.40 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Biora Therapeutics, Inc.
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company\'s targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej